FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205918029> ?p ?o ?g. }

• W4205918029 endingPage "1630" @default.
• W4205918029 startingPage "1619" @default.
• W4205918029 abstract "The Kasabach-Merritt phenomenon (KMP) in kaposiform hemangioendothelioma (KHE) is characterized by life-threatening thrombocytopenia and consumptive coagulopathy. This study compared the efficacy and safety of sirolimus plus prednisolone vs sirolimus monotherapy as treatment strategies for KHE with KMP in the largest cohort to date. Participants were randomized to receive either sirolimus in combination with a short course of prednisolone or sirolimus monotherapy for at least 12 months. The primary outcome was defined as achievement of a durable platelet response (platelet count >100 × 109/L) at week 4. Participants completed efficacy assessments 2 years after the initial treatment. At week 4, a durable platelet response was achieved by 35 of 37 patients given sirolimus and prednisolone compared with 24 of 36 patients given sirolimus monotherapy (difference 27.9%; 95% confidence interval, 10.0-44.7). Compared with the sirolimus monotherapy group, the combination treatment group showed improvements in terms of measures of durable platelet responses at all points during the initial 3-week treatment period, median platelet counts during weeks 1 to 4, increased numbers of patients achieving fibrinogen stabilization at week 4, and objective lesion responses at month 12. Patients receiving combination therapy had fewer blood transfusions and a lower total incidence of disease sequelae than patients receiving sirolimus alone. The frequencies of total adverse events and grade 3-4 adverse events during treatment were similar in both groups. The responses seen in patients with KHE with KMP were profound and encouraging, suggesting that sirolimus plus prednisolone should be considered a valid treatment of KHE with KMP. This trial was registered at www.clinicaltrials.gov as #NCT03188068." @default.
• W4205918029 created "2022-01-26" @default.
• W4205918029 creator A5005149807 @default.
• W4205918029 creator A5024064042 @default.
• W4205918029 creator A5026308896 @default.
• W4205918029 creator A5027448540 @default.
• W4205918029 creator A5033626149 @default.
• W4205918029 creator A5046955110 @default.
• W4205918029 creator A5064388053 @default.
• W4205918029 creator A5065111991 @default.
• W4205918029 creator A5069139703 @default.
• W4205918029 creator A5070538018 @default.
• W4205918029 creator A5078007010 @default.
• W4205918029 creator A5079769050 @default.
• W4205918029 creator A5080232855 @default.
• W4205918029 creator A5091009478 @default.
• W4205918029 date "2022-03-17" @default.
• W4205918029 modified "2023-10-14" @default.
• W4205918029 title "Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial" @default.
• W4205918029 cites W1744607539 @default.
• W4205918029 cites W1764896906 @default.
• W4205918029 cites W1967582033 @default.
• W4205918029 cites W1971312231 @default.
• W4205918029 cites W1998768590 @default.
• W4205918029 cites W2000239178 @default.
• W4205918029 cites W2039973874 @default.
• W4205918029 cites W2048355238 @default.
• W4205918029 cites W2049705652 @default.
• W4205918029 cites W2081913946 @default.
• W4205918029 cites W2094156804 @default.
• W4205918029 cites W2102357022 @default.
• W4205918029 cites W2109730543 @default.
• W4205918029 cites W2115127001 @default.
• W4205918029 cites W2147180420 @default.
• W4205918029 cites W2159110261 @default.
• W4205918029 cites W2159948650 @default.
• W4205918029 cites W2339046472 @default.
• W4205918029 cites W2392938395 @default.
• W4205918029 cites W2418456534 @default.
• W4205918029 cites W2512679820 @default.
• W4205918029 cites W2529794086 @default.
• W4205918029 cites W2588447857 @default.
• W4205918029 cites W2613537880 @default.
• W4205918029 cites W2741305345 @default.
• W4205918029 cites W2744917311 @default.
• W4205918029 cites W2769896015 @default.
• W4205918029 cites W2790988900 @default.
• W4205918029 cites W2795879485 @default.
• W4205918029 cites W2796364945 @default.
• W4205918029 cites W2890377417 @default.
• W4205918029 cites W2895525897 @default.
• W4205918029 cites W2898708409 @default.
• W4205918029 cites W2908509200 @default.
• W4205918029 cites W2914341505 @default.
• W4205918029 cites W2945950716 @default.
• W4205918029 cites W2951964242 @default.
• W4205918029 cites W2953398820 @default.
• W4205918029 cites W3005095383 @default.
• W4205918029 cites W3014011449 @default.
• W4205918029 cites W3096846501 @default.
• W4205918029 cites W3108665905 @default.
• W4205918029 cites W3119552716 @default.
• W4205918029 cites W3126380139 @default.
• W4205918029 cites W3131515942 @default.
• W4205918029 cites W3159863179 @default.
• W4205918029 cites W3165173297 @default.
• W4205918029 cites W3172536500 @default.
• W4205918029 cites W625451847 @default.
• W4205918029 doi "https://doi.org/10.1182/blood.2021014027" @default.
• W4205918029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35030255" @default.
• W4205918029 hasPublicationYear "2022" @default.
• W4205918029 type Work @default.
• W4205918029 citedByCount "30" @default.
• W4205918029 countsByYear W42059180292022 @default.
• W4205918029 countsByYear W42059180292023 @default.
• W4205918029 crossrefType "journal-article" @default.
• W4205918029 hasAuthorship W4205918029A5005149807 @default.
• W4205918029 hasAuthorship W4205918029A5024064042 @default.
• W4205918029 hasAuthorship W4205918029A5026308896 @default.
• W4205918029 hasAuthorship W4205918029A5027448540 @default.
• W4205918029 hasAuthorship W4205918029A5033626149 @default.
• W4205918029 hasAuthorship W4205918029A5046955110 @default.
• W4205918029 hasAuthorship W4205918029A5064388053 @default.
• W4205918029 hasAuthorship W4205918029A5065111991 @default.
• W4205918029 hasAuthorship W4205918029A5069139703 @default.
• W4205918029 hasAuthorship W4205918029A5070538018 @default.
• W4205918029 hasAuthorship W4205918029A5078007010 @default.
• W4205918029 hasAuthorship W4205918029A5079769050 @default.
• W4205918029 hasAuthorship W4205918029A5080232855 @default.
• W4205918029 hasAuthorship W4205918029A5091009478 @default.
• W4205918029 hasBestOaLocation W42059180291 @default.
• W4205918029 hasConcept C126322002 @default.
• W4205918029 hasConcept C141071460 @default.
• W4205918029 hasConcept C197934379 @default.
• W4205918029 hasConcept C2776715498 @default.
• W4205918029 hasConcept C2776999253 @default.
• W4205918029 hasConcept C2777921159 @default.
• W4205918029 hasConcept C71924100 @default.

• next